N Taniguchi Selected Research

N Taniguchi Research Topics

Disease

10	Neoplasms (Cancer) 03/2016 - 01/2000
5	Neoplasm Metastasis (Metastasis) 12/2001 - 05/2000
3	Wounds and Injuries (Trauma) 03/2005 - 06/2000
3	Atherosclerosis 02/2001 - 05/2000
2	Carcinoma (Carcinomatosis) 03/2016 - 10/2011
2	Hepatocellular Carcinoma (Hepatoma) 07/2002 - 12/2000
2	Melanoma (Melanoma, Malignant) 12/2001 - 01/2001
2	Alzheimer Disease (Alzheimer's Disease) 07/2001 - 05/2001
2	Hyperplasia 03/2001 - 06/2000
2	Atherosclerotic Plaque (Atheroma) 02/2001 - 05/2000
2	Reperfusion Injury 10/2000 - 07/2000
2	Myocardial Infarction 10/2000 - 07/2000
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 07/2000 - 01/2000
2	Colonic Neoplasms (Colon Cancer) 02/2000 - 01/2000
1	Osteolysis 01/2018
1	Asthma (Bronchial Asthma) 01/2018
1	Carcinogenesis 03/2016
1	Stomach Neoplasms (Stomach Cancer) 03/2016
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2011
1	Weight Loss (Weight Reduction) 01/2011
1	Dental Caries (Decay, Dental) 06/2010
1	Endocarditis 06/2010
1	Pigmented Villonodular Synovitis 06/2005
1	Rheumatoid Arthritis 06/2005
1	Mitochondrial Diseases (Mitochondrial Disease) 06/2005
1	Osteoarthritis 06/2005
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2001
1	Experimental Melanoma 12/2001
1	Ganglion Cysts (Ganglion) 05/2001
1	Camurati-Engelmann Syndrome (Progressive Diaphyseal Dysplasia) 04/2001
1	Heart Diseases (Heart Disease) 03/2001
1	Chronic Hepatitis (Chronic Active Hepatitis) 03/2001
1	Liver Cirrhosis (Hepatic Cirrhosis) 03/2001

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2011 - 05/2000
5	Polysaccharides (Glycans)IBA 03/2016 - 01/2000
4	LectinsIBA 07/2002 - 01/2000
3	alpha-1,6-mannosylglycoprotein beta 1,6-N-acetylglucosaminyltransferaseIBA 12/2001 - 01/2000
3	EnzymesIBA 05/2001 - 07/2000
3	Superoxide DismutaseIBA 10/2000 - 07/2000
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2011
2	Cadherins (E-Cadherin)IBA 03/2016 - 01/2001
2	Glucose (Dextrose)FDA LinkGeneric 01/2011 - 05/2001
2	AlbuminsIBA 01/2011 - 05/2001
2	Peptides (Polypeptides)IBA 06/2005 - 04/2001
2	Glycoproteins (Glycoprotein)IBA 12/2001 - 12/2000
2	Messenger RNA (mRNA)IBA 12/2001 - 01/2000
2	Advanced Glycation End ProductsIBA 07/2001 - 05/2001
2	Free RadicalsIBA 07/2001 - 09/2000
2	Monoclonal AntibodiesIBA 03/2001 - 05/2000
2	AntioxidantsIBA 03/2001 - 12/2000
2	AcetylglucosamineIBA 03/2001 - 05/2000
2	OligosaccharidesIBA 03/2001 - 12/2000
2	Adrenocorticotropic Hormone (ACTH)FDA Link 02/2001 - 11/2000
2	Tyrosine (L-Tyrosine)FDA Link 01/2001 - 05/2000
2	Arginine Vasopressin (Argipressin)IBA 01/2001 - 01/2000
2	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 01/2001 - 01/2000
2	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 10/2000 - 05/2000
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2000 - 07/2000
2	OligodeoxyribonucleotidesIBA 10/2000 - 07/2000
2	IsoenzymesIBA 09/2000 - 04/2000
1	Polyethylene (Polythene)IBA 01/2018
1	AsparagineIBA 03/2016
1	MucinsIBA 10/2011
1	Lipoproteins (Lipoprotein)IBA 01/2011
1	CholesterolIBA 01/2011
1	Cysteine (L-Cysteine)FDA Link 01/2011
1	LipidsIBA 01/2011
1	IDL Lipoproteins (Lipoprotein, IDL)IBA 01/2011
1	GlucosyltransferasesIBA 06/2010
1	glucosyltransferase D (GtfD)IBA 06/2010
1	humaninIBA 06/2005
1	Culture MediaIBA 07/2002
1	3,7,11,15- tetramethyl- 2,4,6,10,14- hexadecapentaenoic acidIBA 07/2002
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 07/2002
1	Pharmaceutical PreparationsIBA 07/2002
1	FucosyltransferasesIBA 07/2002
1	Protein Kinases (Protein Kinase)IBA 12/2001
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 12/2001
1	Estrogens (Estrogen)FDA Link 12/2001
1	Melanocyte-Stimulating Hormones (MSH)IBA 12/2001
1	Melanins (Melanin)IBA 12/2001
1	Integrin beta1IBA 12/2001
1	hexitolIBA 07/2001
1	N(6)-carboxymethyllysine (carboxymethyllysine)IBA 07/2001
1	Oxygen (Dioxygen)IBA 07/2001
1	Lysine (L-Lysine)FDA Link 07/2001
1	Prealbumin (Transthyretin)IBA 05/2001
1	ApolipoproteinsIBA 05/2001
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 04/2001
1	Transforming Growth Factors (Transforming Growth Factor)IBA 04/2001
1	Uridine Diphosphate (UDP)IBA 03/2001
1	Streptozocin (Streptozotocin)FDA Link 03/2001
1	N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase (N-acetylglucosaminyltransferase)IBA 03/2001
1	MannosidesIBA 03/2001
1	low density lipoprotein inhibitorIBA 02/2001

Therapy/Procedure

1	Hip Replacement Arthroplasty (Total Hip Replacement) 01/2018
1	Thoracotomy 03/2005
1	Thoracoscopes 03/2005
1	Aftercare (After-Treatment) 07/2002
1	Secondary Prevention 07/2002